108 related articles for article (PubMed ID: 28524143)
1. [Features of psycho-emotional state of patients with central serous chorioretinopathy].
Shchuko AA; Yureva TN; Zlobina AN
Vestn Oftalmol; 2017; 133(2):70-74. PubMed ID: 28524143
[TBL] [Abstract][Full Text] [Related]
2. Vision-related quality of life in patients with chronic central serous chorioretinopathy.
Türkcü FM; Şahin A; Bez Y; Yüksel H; Cinar Y; Kürşat Cingü A; Çaça İ
Semin Ophthalmol; 2015 Jul; 30(4):272-5. PubMed ID: 24164250
[TBL] [Abstract][Full Text] [Related]
3. Psychological distress and poor quality of life in patients with central serous chorioretinopathy.
Sahin A; Bez Y; Kaya MC; Türkcü FM; Sahin M; Yüksel H
Semin Ophthalmol; 2014 Mar; 29(2):73-6. PubMed ID: 23758338
[TBL] [Abstract][Full Text] [Related]
4. Personality Traits, Stress, and Emotional Intelligence Associated with Central Serous Chorioretinopathy.
Sesar AP; Sesar A; Bucan K; Sesar I; Cvitkovic K; Cavar I
Med Sci Monit; 2021 Jan; 27():e928677. PubMed ID: 33423036
[TBL] [Abstract][Full Text] [Related]
5. Temperament profile in patients with central serous chorioretinopathy: a case-control study.
Piskunowicz M; Jaracz M; Lesiewska H; Malukiewicz G; Brozek-Pestka M; Borkowska A
Eur J Ophthalmol; 2014; 24(3):392-5. PubMed ID: 24170517
[TBL] [Abstract][Full Text] [Related]
6. Central serous chorioretinopathy: Professional repercussions among agents of the internal security forces.
Lajmi H; Hmaied W; Ben Jalel W; Akremi A; El Fekih L
J Fr Ophtalmol; 2018 Oct; 41(8):739-743. PubMed ID: 30217609
[TBL] [Abstract][Full Text] [Related]
7. Psychological factors associated with acute and chronic central serous chorioretinopathy.
Lahousen T; Painold A; Luxenberger W; Schienle A; Kapfhammer HP; Ille R
Nord J Psychiatry; 2016; 70(1):24-30. PubMed ID: 25947110
[TBL] [Abstract][Full Text] [Related]
8. In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy.
Bazzazi N; Ahmadpanah M; Akbarzadeh S; Seif Rabiei MA; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2015; 11():1131-6. PubMed ID: 25995637
[TBL] [Abstract][Full Text] [Related]
9. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional personality beliefs and psychopathology in patients with central serous chorioretinopathy.
Çam F; Sevik MO; Aykut A; Dericioğlu V; Şahin Çam C; Şahin Ö
J Fr Ophtalmol; 2024 Feb; 47(2):103997. PubMed ID: 37919151
[TBL] [Abstract][Full Text] [Related]
11. Relationship between mean platelet volume and central serous chorioretinopathy.
Dursun A; Toker MI; Ozec AV; Bozali E; Kirboga K; Dursun FG; Erdogan H; Topalkara A; Arici MK
Int Ophthalmol; 2017 Feb; 37(1):119-124. PubMed ID: 27113057
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of acute vision loss: central serous chorioretinopathy.
Pare JR; Guo Y; Schechter-Perkins EM
Am J Emerg Med; 2014 Apr; 32(4):396.e3-4. PubMed ID: 24342864
[TBL] [Abstract][Full Text] [Related]
14. [OCT-morphometric and angiographic parallels between different variants of central serous chorioretinopathy].
Panova IE; Shaimov TB; Shaimova VA
Vestn Oftalmol; 2017; 133(2):10-17. PubMed ID: 28524134
[TBL] [Abstract][Full Text] [Related]
15. Shift Work: A Risk Factor for Central Serous Chorioretinopathy.
Bousquet E; Dhundass M; Lehmann M; Rothschild PR; Bayon V; Leger D; Bergin C; Dirani A; Beydoun T; Behar-Cohen F
Am J Ophthalmol; 2016 May; 165():23-8. PubMed ID: 26915576
[TBL] [Abstract][Full Text] [Related]
16. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
[TBL] [Abstract][Full Text] [Related]
17. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study.
Bae S; Jin K; Kim H; Bae SH
BMC Ophthalmol; 2015 Dec; 15():180. PubMed ID: 26677843
[TBL] [Abstract][Full Text] [Related]
18. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Chen TJ; Lin SJ; Chen JW; Leu HB
Br J Ophthalmol; 2012 Dec; 96(12):1484-8. PubMed ID: 22976583
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Leu HB
Acta Ophthalmol; 2013 Nov; 91(7):666-71. PubMed ID: 22998678
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.
Chang YS; Weng SF; Chang C; Wang JJ; Wang JY; Jan RL
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4083-9. PubMed ID: 26114485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
